Feagan BG et al., Clin Gastroenterol Hepatol., 2017
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Diese Publikation steht Ihnen auf Pubmed zur Verfügung.